Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Apr 17 2026

Apr 17, 2026 at 6:34 PM EDT · Issued by Aurobindo Pharma Ltd

Filed with NSE · Apr 17, 2026 at 6:34 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/press-release-apr-17-2026-3

Release

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 17, 2026, titled "Aurobindo Pharma receives USFDA approval for Dextromethorphan Polistirex Extended-Release Oral Suspension, 30 mg/5 mL (OTC)".

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Press Release Apr 07 2026Apr 7
Press Release Apr 06 2026Apr 6
Press Release Mar 04 2026Mar 4
Press Release Feb 26 2026Feb 26
Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040Feb 17

Later from Aurobindo Pharma

Press Release May 21 2026May 21
Press Release Jun 03 2026Jun 3
Press Release Jun 04 2026Jun 4
Aurobindo Pharma Ltd Press Release Jun 22 2026Jun 21
Aurobindo Pharma Ltd Press Release Jul 24 2026Jul 24

All Aurobindo Pharma news releases

Follow Aurobindo Pharma into a list and get an email when it puts out news.

Follow Aurobindo Pharma